The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Editor’s Choice for May 2018

Published: 21 May 2018

Views: 2060

Rating:

Save

Prof Gordon McVie - Founding Editor, ecancer

	Video
	Prostate Cancer Debate, Madrid
	Cancer Research UK Brain Cancer Conference, London
	Myeloma Knowledge Exchange, Vienna
	Education
	Breast Cancer CDK 4/6 Inhibitors and Osteonecrosis of the Jaw, multiple languages
	Journal
	Case Report: Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis
	Case Report: Successful treatment of a stage IIIC small-cell carcinoma of the ovary hypercalcemic subtype using multi-modality therapeutic approach
	Review: Postoperative radiotherapy after nipple- or skin-sparing mastectomy: a review of recent institutional and pooled data
	Review: Aggressive breast fibromatosis following augmentation mastoplasty: a series of case reports
	Case Report: Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
	Research
	PIONEER Prostate Cancer
	Conferences
	ecancer Argentina Palliative Care
	ecancer Chile Clinical Oncology

Related Videos

AORTIC 2021: Goals of AORTIC

Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana

AORTIC 2021: Goals of AORTIC ( Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana )

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...

Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer ( Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy )

Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...

Dr Terence Friedlander - UCSF, San Francisco, USA

Long term outcome of enfortumab vedotin + pembrolizumab in first line locally advanced or metastatic urothelial carcinoma ( Dr Terence Friedlander - UCSF, San Francisco, USA )

Updates on criteria for patient selection and surgical management in advanced ov...

Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA

Updates on criteria for patient selection and surgical management in advanced ovarian cancer ( Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA )

What is global oncology and what is the presence of global oncology in Europe

Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...

What is global oncology and what is the presence of global oncology in Europe ( Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', Bucharest,Romania )

ESMO 2020 melanoma roundup

Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany

ESMO 2020 melanoma roundup ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )

PARP inhibitors and their evolving role for the treatment of prostate cancer

Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi

PARP inhibitors and their evolving role for the treatment of prostate cancer ( Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi )

Future perspective of CDH1 mutation in gastric and breast cancers

Dr. Giovanni Corso - University of Milan, Italy, Meeting president

Future perspective of CDH1 mutation in gastric and breast cancers ( Dr. Giovanni Corso - University of Milan, Italy, Meeting president )

IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA

IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )

More from ecancer